serine has been researched along with ag-490 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erwin, RA; Farrar, WL; Kirken, RA; Rui, H; Wang, L; Wang, Y | 1 |
Behbod, F; Erwin-Cohen, RA; Kahan, BD; Kirken, RA; Qu, X; Stepkowski, SM; Trawick, BW; Verani, R; Wang, ME | 1 |
Bencherif, M; Marrero, MB; Shaw, S | 1 |
Bencherif, M; Bhatti, BS; Marrero, MB; Papke, RL; Shaw, S | 1 |
4 other study(ies) available for serine and ag-490
Article | Year |
---|---|
Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Topics: Cell Line, Transformed; Cell Transformation, Neoplastic; Cell Transformation, Viral; DNA-Binding Proteins; Enzyme Inhibitors; Growth Inhibitors; Human T-lymphotropic virus 1; Humans; Immunosuppressive Agents; Interleukin-15; Interleukin-2; Janus Kinase 3; Lymphocyte Activation; Milk Proteins; NF-kappa B; Nuclear Proteins; Phosphorylation; Phytohemagglutinins; Protein-Tyrosine Kinases; Serine; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes; Trans-Activators; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine; Tyrphostins | 2000 |
Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cell Division; Cell Line; Cell Movement; Cell Nucleus; Cells, Cultured; DNA; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Graft Enhancement, Immunologic; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Injections, Intraperitoneal; Interleukin-2; Janus Kinase 3; Leukocytes, Mononuclear; Milk Proteins; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Receptors, Interleukin-2; Serine; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes; Trans-Activators; Tumor Suppressor Proteins; Tyrosine; Tyrphostins | 2001 |
Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Bungarotoxins; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Janus Kinase 2; Neuroprotective Agents; Nicotine; Nicotinic Agonists; PC12 Cells; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Receptors, Nicotinic; Serine; Signal Transduction; Tyrosine; Tyrphostins | 2002 |
The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiotensin II; Animals; Apoptosis; Bridged Bicyclo Compounds; Drosophila Proteins; Enzyme Activation; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Receptors, Nicotinic; Serine; Tyrosine; Tyrphostins | 2004 |